Xencor (XNCR) Goodwill & Intangibles (2013 - 2026)
Xencor's (XNCR) quarterly Goodwill & Intangibles came in at $7.6 million in Q1 2026, down 43.11% year-on-year from $13.4 million in Q1 2025, and down 9.34% on a QoQ basis from $8.4 million in Q4 2025.
Xencor (XNCR) Goodwill & Intangibles (2013 - 2026) Analysis & Trends
Xencor (XNCR) has 14 years of Goodwill & Intangibles data on file, last reported at $7.6 million in Q1 2026.
- On a quarterly basis, Goodwill & Intangibles fell 43.11% year-over-year to $7.6 million in Q1 2026; TTM through Mar 2026 was $7.6 million, a 43.11% decrease from a year earlier, with the FY2025 full-year figure at $8.4 million, down 54.64% from the prior year.
- Goodwill & Intangibles for Q1 2026 stood at $7.6 million, down from $8.4 million in the prior quarter.
- Over the last five years, Goodwill & Intangibles for XNCR reached as high as $18.9 million in Q1 2024 and fell as low as $7.6 million in Q1 2026.
- Historically, Goodwill & Intangibles has averaged $15.9 million across 5 years, with a median of $18.1 million in 2022.
- Across the five-year window, Goodwill & Intangibles gained 12.17% in 2022 and tumbled 54.64% in 2025, its largest moves.
- Year by year, Goodwill & Intangibles stood at $18.5 million in 2022, then increased by 0.88% to $18.7 million in 2023, then slipped by 0.95% to $18.5 million in 2024, then tumbled by 54.64% to $8.4 million in 2025, then dropped by 9.34% to $7.6 million in 2026.
- Per Business Quant data, the three most recent Goodwill & Intangibles figures were $7.6 million in Q1 2026, $8.4 million in Q4 2025, and $9.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,719.23 Bn | 65,718.94 Bn | - |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 471.85 Bn | 467.06 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.29 Bn | 115.04 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.04 Bn | 61.28 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.06 Bn | 62.06 Bn | - |
| 8 | Argenx Se | 55.78 Bn | 50.60 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.47 Bn | 34.47 Bn | 959.66 Mn |
| 10 | Xencor | 1.50 Bn | 1.11 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.60 Mn |
| Dec 31, 2025 | 8.39 Mn |
| Sep 30, 2025 | 9.47 Mn |
| Jun 30, 2025 | 11.25 Mn |
| Mar 31, 2025 | 13.36 Mn |
| Dec 31, 2024 | 18.49 Mn |
| Sep 30, 2024 | 17.92 Mn |
| Jun 30, 2024 | 18.78 Mn |
| Mar 31, 2024 | 18.85 Mn |
| Dec 31, 2023 | 18.66 Mn |
| Sep 30, 2023 | 18.74 Mn |
| Jun 30, 2023 | 18.71 Mn |
| Mar 31, 2023 | 18.24 Mn |
| Dec 31, 2022 | 18.50 Mn |
| Sep 30, 2022 | 18.09 Mn |
| Jun 30, 2022 | 17.94 Mn |
| Mar 31, 2022 | 16.71 Mn |
| Dec 31, 2021 | 16.49 Mn |
| Sep 30, 2021 | 16.68 Mn |
| Jun 30, 2021 | 16.38 Mn |